News

Replying on Arthrex, the Smith & Nephew Reply Brief

By EsqSocial Corporation 02/02/21

Smith & Nephew and the United States filed their reply briefs on January 22. Smith & Nephew’s reply brief, which we review here, critiques the arguments Arthrex made in its initial merits brief, addresses some issues raised in amicus briefs, and shores up its own positions.

Mandatory GHG Corporate Disclosure Bill Introduced in California

By EsqSocial Corporation 02/02/21

A California state legislator has introduced a bill that would require large corporations doing business in the state to publicly disclose their greenhouse gas emissions (GHGs).

NYS Attorney General Report on Underreported Nursing Home Deaths Underscores Importance of Compliance and Preparation

By EsqSocial Corporation 02/02/21

Late last week New York Attorney General Letitia James released a report that found the state Department of Health underreported COVID-19 deaths of nursing home residents by as much as 50 percent.

Widening the Aperture Beyond Retail-Focused Advisers

By EsqSocial Corporation 02/02/21

SEC Enforcement and Exams Likely to Focus More on Private Funds in the New Administration - For the next several weeks and months, intense focus will be trained on determining the priorities of the Biden administration.

Banking and finance regulatory news, February 2021

By EsqSocial Corporation 02/02/21

Capital buffers: PRA modification by consent - The UK Prudential Regulation Authority (PRA) has published a direction for modification by consent of 5.1 - 5.3 and 5.5 of the Capital Buffers Part of the PRA Rulebook....

AstraZeneca Sues HHS over Drug Pricing Program Advisory Opinion Regarding Contract Pharmacies

By EsqSocial Corporation 02/02/21

On January 12, 2021, AstraZeneca Pharmaceuticals LP filed a complaint in Delaware federal court against the Department of Health and Human Services (HHS) for issuing an invalid Advisory Opinion. The 340B Drug Pricing Program, 42 U.S.C. § 256b (Section 340B) ......

Blockbuster Biologics Review | Quarterly Update – February 2021

By EsqSocial Corporation 02/02/21

Welcome to our quarterly update relating to biologics and biosimilars, including post-grant and patent litigation challenges to blockbuster biologics.

Best Professional Judgment for Cooling Water Intake Structures at Hydroelectric Facilities: U.S. Environmental Protection Agency Memorandum

By EsqSocial Corporation 02/02/21

The U.S.

Gold Dome Report — Legislative Day 9

By EsqSocial Corporation 02/02/21

After a marathon of Senate budget subcommittee meetings to close last week, the General Assembly reconvened with a bit of lethargy. Although the Senate did take up three propositions that each earned easy passage, the House floor and committee calendar was relatively quiet.

HSR Thresholds Will Decrease for 2021 Transactions

By EsqSocial Corporation 02/02/21

Size-of-transaction threshold under Hart-Scott-Rodino Act will decrease to $92 million; the first threshold decrease since 2010. As a result of the decrease in the U.S.

Pages